课题基金 / 基金详情

Analysis of anti-interferon mechanism by HCV NS5A protein using HCV replicon system

Analysis of anti-interferon mechanism by HCV NS5A protein using HCV replicon system
利用HCV复制子系统分析HCV NS5A蛋白抗干扰素机制
批准号:
14370175
负责人:
ENOMOTO Nobuyuki
金额:
$8.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

ENOMOTO Nobuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatitis C virus (HCV) subgenomic replicon has been reported to replicate efficiently and continuously in human hepatoma Huh-7 cells. We have extended these results to other isolated HCV clones, and we have constructed another HCV replicon from HC-J4, one of the chimpanzee-infectious clones. An HCV replieon (RpJ4) was constructed from a chimpanzee-infectious clone, HC-J4, which consists of HCV-5'-UTR, neomycin phosphotransferase gene, the encephalomyocarditis virus IRES, HCV-non-structural region, NS3 to NS5B, and HCV-3'-UTR. The adaptive mutations known to be required for HCV-Con1 replicon were introduced in RpJ4 replicon, aa.(amino acids number according to HC-J4) 2197 serine to praline, aa.2201 serine to deletion, and aa.2204 serine to isoleucine (RpJ4-S2197P, RpJ4-S22001del, and RpJ4-S2204I). RpJ4/ISDRmutant and RpJ4-S2201del/ISDRmutant were also constructed by introducing six amino acid mutations into the interferon sensitivity determining region (ISDR). Replieon RNA was transfec … More ted into Huh-7 cells, and stable replicon-expressing cell lines were established by G418 selection. After transfection to naive Huh-7 cells, RpJ4 and RpJ4/ISDRmutants did not produce any G418-resistant colonies. In contrast, G418-resistant cells were transduced efficiently by the introduction of RpJ4-S2197P, RpJ4-S2204I, RpJ4-S2201del and RpJ4-S2201del/ISDRmutants, with the RpJ4-S2201del/ISDR mutant being most efficient. The HCV replioon derived from HC-J4 can replicate efficiently following the introduction of adaptive mutations into the upstream region of ISDR Moreover, additional introduction of mutations into ISDR further enhances its replication. These findings demonstrate that the genetic structure of the NS5A domain is critical in HCV-1b replications, for both the HCV-Con1 and the HC-J4 replicons.Cellular antiviral responses are mediated partly by the expression of interferon-stimulated genes, triggered by viral genomes, their transcripts and replicative intermediates. Persistent replication of a hepatitis C virus (HCV) replicon suggests that the replicon does not elicit cellular innate antiviral responses. In the present study, we investigated regulatory factors of the IFN-mediated antiviral system in cells expressing an HCV replieon. Luciferase reporter assays revealed that the baseline activity of the interferon-stimulated response element (ISRE) was significantly lower in cells harboring the replicon than in naive cells. Among the proteins involved in the IFN/Jak/STAT pathway and in ISRE activity, the expression level of interferon regulatory factor-1 (IRF-1) was found to be significantly lower in cells harboring the replicon. Transfection of an IRF-1 expression construct into cells harboring the replieon caused an increase of ISRE activity, accompanied by suppression of expression of the HCV replieon. Moreover in cured Huh7 cells, from which the HCV replicon had been eliminated, expression levels of IRF-1 and ISRE activity also were suppressed, demonstrating that the decrease of IRF-1 is attributable, not to active suppression by the viral proteins, but to adaptation of cells that enables replication of the HCV subgenome. The high permissiveness of the cured cells for the replicon was abolished by transgenic supplementation of IRF-1 expression. Taken together, IRF-1 is one of the key host factors that regulate intracellular HCV replication through modulation of ISG-mediated antiviral responses. Less
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
Sakamoto N, Yokota T, et al.: "Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived siRNAs"EMBO Roports. 4. 602-608 (2003)
Sakamoto N、Yokota T 等人:“通过合成和载体衍生的 siRNA 抑制细胞内丙型肝炎病毒复制”EMBO Roports。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Maekawa S, Sakamoto N, et al.: "Introduction of NS5A Mutations Enables Subgenomic HCV-Replicon Derived from Chmpanzee-Infectious HC-J4 Isolate to Replicate Efficiently in Huh-7 Cells"J Viral Hepatitis. in press. (2004)
Maekawa S、Sakamoto N 等人:“NS5A 突变的引入使得源自黑猩猩感染性 HC-J4 分离株的亚基因组 HCV 复制子能够在 Huh-7 细胞中有效复制”J 病毒性肝炎。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sakamoto N, et al.: "Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon-alpha"J Infect Dis. in press. (2004)
Sakamoto N 等人:“利巴韦林和干扰素-α 组合对细胞内丙型肝炎病毒复制的协同抑制”J Infect Dis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1016/j.hepres.2004.02.014
发表时间: 2004-06-01
期刊: HEPATOLOGY RESEARCH
影响因子: 4.2
作者: [Ueda, E, Enomoto, N, Watanabe, M]
通讯作者: Watanabe, M
11
    Next-generation sequence of cancer-related genes in digestive organ cancers using clinical samples
    • 批准号:
      26670380
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      ENOMOTO Nobuyuki
    • 依托单位:
    Clarifying the pathogenesis of chronic hepatitis C through comprehensive genetic analyses of the virus and host using next-generation sequencer
    • 批准号:
      23390195
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2011
    • 负责人:
      ENOMOTO Nobuyuki
    • 依托单位:
    Analysis ofchronic viral hepaptis by the large-scale next generation sequeincing
    • 批准号:
      21659186
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.11万
    • 财政年份:
      2009
    • 负责人:
      ENOMOTO Nobuyuki
    • 依托单位:
    Comprehensive analysis of chronic hepatitis C by large-scale viral genome wide analysis
    • 批准号:
      20390206
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2008
    • 负责人:
      ENOMOTO Nobuyuki
    • 依托单位:
    海外基金